Patents Assigned to MacroGenics West, Inc.
  • Publication number: 20140328857
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Application
    Filed: June 3, 2014
    Publication date: November 6, 2014
    Applicant: MACROGENICS WEST, INC.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • Patent number: 8779098
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: July 15, 2014
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • Patent number: 8361475
    Abstract: The invention provides the identification and characterization of a disease and cancer-associated antigen, KID24. The invention also provides modulators of KID24, including a family of monoclonal antibodies that bind to antigen KID24, and methods of diagnosing and treating various human cancers and diseases with KID24.
    Type: Grant
    Filed: January 14, 2010
    Date of Patent: January 29, 2013
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Deryk T. Loo
  • Patent number: 8313916
    Abstract: The invention provides the identification and characterization of a disease and cancer-associated antigen, KID31. The invention also provides modulators of KID31, including a family of monoclonal antibodies that bind to antigen KID31, and methods of diagnosing and treating various human cancers and diseases with KID31.
    Type: Grant
    Filed: February 13, 2010
    Date of Patent: November 20, 2012
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Deryk T. Loo
  • Patent number: 8309354
    Abstract: This invention discloses isolated populations of human cancer stem cells. Methods for characterizing, isolating and culturing human cancer stem cells are also disclosed. Uses for human cancer stem cells are provided.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: November 13, 2012
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts
  • Publication number: 20110045006
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, LUCA2. The invention also provides a family of monoclonal antibodies that bind to antigen LUCA2, methods of diagnosing and treating various human cancers and diseases that express LUCA2.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 24, 2011
    Applicant: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts